The global obesity GLP-1 market is valued at USD 8,169 million in 2025
The compounding process is regulated by state pharmacy boards and, for 503B facilities, by the FDA
Regular follow-ups, balanced eating, and consistent activity help preserve results, with some individuals continuing semaglutide as needed
this heterogeneity may have affected the results
GLP-1 medications naturally reduce how much you want to eat at one time
This unique mechanism has shown unprecedented results in early clinical trials, with participants losing over 24% of their body weight in less than a year at the highest studied doses Because of its potency, dosing strategy is at the center of how Retatrutide works